TRANSTHERA SCIENCES (NANJING), INC. - B - H SHARES
(HKEX: 2617)

TransThera Sciences (Nanjing), Inc. engages in the research and development of clinical biopharmaceutics. It focuses on the discovery and development of small molecule innovative therapies for tumors, inflammations, and cardiovascular diseases. The company was founded by Frank Wu on April 15, 2014 and is headquartered in Nanjing, China.

69.900 -

-1.300 (-1.83%)
价格区间 69.100 - 71.950   (4.12%)
开盘 71.300
昨收 71.200
买 69.900
买盘 ('000) 7
卖 70.350
卖盘 ('000) 1.5
成交量 ('000) 557
成交额 39,009,350
注释 -
数据延迟。最后一次更新12 Feb 2026 16:08.
数据提供商
查看所有活动

Loading Chart...

Please login to view stock data and analysis